Login Register Cart 0
Generic placeholder image

Current Stem Cell Research & Therapy

Editor-in-Chief

ISSN (Print): 1574-888X
ISSN (Online): 2212-3946

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Effectiveness of Dental Pulp-derived Stem Cells and Bone Marrowderived Mesenchymal Stromal Cells Implanted into a Murine Critical Bone Defect

Author(s): Corina Vater*, Christian Männel, Julia Bolte, Xinggui Tian, Stuart B. Goodman and Stefan Zwingenberger

Volume 17, Issue 5, 2022

Published on: 15 February, 2022

Page: [480 - 491] Pages: 12

DOI: 10.2174/1574888X17666220215100732

Price: $65

conference banner
Abstract

Background: While bone marrow-derived mesenchymal stromal cells (BM-MSCs) have been used for many years in bone tissue engineering applications, the procedure still has drawbacks such as painful collection methods and damage to the donor site. Dental pulp-derived stem cells (DPSCs) are readily accessible, occur in high amounts, and show a high proliferation and differentiation capability. Therefore, DPSCs may be a promising alternative for BM-MSCs to repair bone defects.

Objective: The aim of this study was to investigate the bone regenerative potential of DPSCs in comparison to BM-MSCs in vitro and in vivo.

Methods: In vitro investigations included analysis of cell doubling time as well as proliferation and osteogenic differentiation. For the in vivo study, 36 male NMRI nude mice were randomized into 3 groups: 1) control (cell-free mineralized collagen matrix (MCM) scaffold), 2) MCM + DPSCs, and 3) MCM + BMMSCs. Critical size 2 mm bone defects were created at the right femur of each mouse and stabilized by an external fixator. After 6 weeks, animals were euthanized, and microcomputed tomography scans (μCT) and histological analyses were performed.

Results: In vitro DPSCs showed a 2-fold lower population doubling time and a 9-fold higher increase in proliferation when seeded onto MCM scaffolds as compared to BM-MSCs, but DPSCs showed a significantly lower osteogenic capability than BM-MSCs. In vivo, the healing of the critical bone defect in NMRI nude mice was comparable among all groups.

Conclusion: Pre-seeding of MCM scaffolds with DPSCs and BM-MSCs did not enhance bone defect healing.

Keywords: Dental pulp-derived stem cells, bone marrow-derived mesenchymal stromal cells, critical bone defect, mouse model, bone tissue engineering, bone regeneration.

« Previous
Graphical Abstract

[1]
Abdel Meguid E, Ke Y, Ji J, El-Hashash AHK. Stem cells applications in bone and tooth repair and regeneration: New insights, tools, and hopes. J Cell Physiol 2018; 233(3): 1825-35.
[http://dx.doi.org/10.1002/jcp.25940] [PMID: 28369866]
[2]
Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 2000; 97(25): 13625-30.
[http://dx.doi.org/10.1073/pnas.240309797] [PMID: 11087820]
[3]
Tsutsui TW. Dental pulp stem cells: Advances to applications. Stem Cells Cloning 2020; 13: 33-42.
[http://dx.doi.org/10.2147/SCCAA.S166759] [PMID: 32104005]
[4]
Lizier NF, Kerkis A, Gomes CM, et al. Scaling-up of dental pulp stem cells isolated from multiple niches. PLoS One 2012; 7(6): e39885.
[http://dx.doi.org/10.1371/journal.pone.0039885] [PMID: 22768154]
[5]
Janicki P, Boeuf S, Steck E, Egermann M, Kasten P, Richter W. Prediction of in vivo bone forming potency of bone marrow-derived human mesenchymal stem cells. Eur Cell Mater 2011; 21: 488-507.
[http://dx.doi.org/10.22203/eCM.v021a37] [PMID: 21710441]
[6]
Alge DL, Zhou D, Adams LL, et al. Donor-matched comparison of dental pulp stem cells and bone marrow-derived mesenchymal stem cells in a rat model. J Tissue Eng Regen Med 2010; 4(1): 73-81.
[http://dx.doi.org/10.1002/term.220] [PMID: 19842108]
[7]
Rajendran R, Gopal S, Masood H, Vivek P, Deb K. Regenerative potential of dental pulp mesenchymal stem cells harvested from high caries patient’s teeth. J Stem Cells 2013; 8(1): 25-41.
[PMID: 24459811]
[8]
Kunimatsu R, Nakajima K, Awada T, et al. Comparative characterization of stem cells from human exfoliated deciduous teeth, dental pulp, and bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun 2018; 501(1): 193-8.
[http://dx.doi.org/10.1016/j.bbrc.2018.04.213] [PMID: 29730288]
[9]
Stiehler M, Rauh J, Bünger C, et al. in vitro characterization of bone marrow stromal cells from osteoarthritic donors. Stem Cell Res (Amst) 2016; 16(3): 782-9.
[http://dx.doi.org/10.1016/j.scr.2016.03.013] [PMID: 27155399]
[10]
Gelinsky M, Welzel PB, Simon P, Bernhardt A, König U. Porous three-dimensional scaffolds made of mineralised collagen: Preparation and properties of a biomimetic nanocomposite material for tissue engineering of bone. Chem Eng J 2008; 137: 84-96.
[http://dx.doi.org/10.1016/j.cej.2007.09.029]
[11]
Bolte J, Vater C, Culla AC, et al. Two-step stem cell therapy improves bone regeneration compared to concentrated bone marrow therapy. J Orthop Res 2019; 37(6): 1318-28.
[http://dx.doi.org/10.1002/jor.24215] [PMID: 30628121]
[12]
Huo MH, Troiano NW, Pelker RR, Gundberg CM, Friedlaender GE. The influence of ibuprofen on fracture repair: Biomechanical, biochemical, histologic, and histomorphometric parameters in rats. J Orthop Res 1991; 9(3): 383-90.
[http://dx.doi.org/10.1002/jor.1100090310] [PMID: 2010842]
[13]
Lee Y-C, Chan Y-H, Hsieh S-C, Lew W-Z, Feng S-W. Comparing the osteogenic potentials and bone regeneration capacities of bone marrow and dental pulp mesenchymal stem cells in a rabbit calvarial bone defect model. Int J Mol Sci 2019; 20(20): E5015.
[http://dx.doi.org/10.3390/ijms20205015] [PMID: 31658685]
[14]
Merckx G, Hosseinkhani B, Kuypers S, et al. Angiogenic effects of human dental pulp and bone marrow-derived mesenchymal stromal cells and their extracellular vesicles. Cells 2020; 9(2): 312.
[http://dx.doi.org/10.3390/cells9020312] [PMID: 32012900]
[15]
Xu F, Wu Y, Zhang Y, Yin P, Fang C, Wang J. Influence of in vitro differentiation status on the in vivo bone regeneration of cell/chitosan microspheres using a rat cranial defect model. J Biomater Sci Polym Ed 2019; 30(12): 1008-25.
[http://dx.doi.org/10.1080/09205063.2019.1619959] [PMID: 31159676]
[16]
Harvestine JN, Gonzalez-Fernandez T, Sebastian A, et al. Osteogenic preconditioning in perfusion bioreactors improves vascularization and bone formation by human bone marrow aspirates. Sci Adv 2020; 6(7): eaay2387.
[http://dx.doi.org/10.1126/sciadv.aay2387] [PMID: 32095526]
[17]
Castano-Izquierdo H, Álvarez-Barreto J, van den Dolder J, Jansen JA, Mikos AG, Sikavitsas VI. Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential. J Biomed Mater Res A 2007; 82(1): 129-38.
[http://dx.doi.org/10.1002/jbm.a.31082] [PMID: 17269144]
[18]
Chatterjea A, LaPointe VL, Barradas A, et al. Cell aggregation enhances bone formation by human mesenchymal stromal cells. Eur Cell Mater 2017; 33: 121-9.
[http://dx.doi.org/10.22203/eCM.v033a09] [PMID: 28198985]
[19]
Liao H-T, Chen C-T. Osteogenic potential: Comparison between bone marrow and adipose-derived mesenchymal stem cells. World J Stem Cells 2014; 6(3): 288-95.
[http://dx.doi.org/10.4252/wjsc.v6.i3.288] [PMID: 25126378]
[20]
Zhang Y, Xing Y, Jia L, et al. An in vitro comparative study of multisource derived human mesenchymal stem cells for bone tissue engineering. Stem Cells Dev 2018; 27(23): 1634-45.
[http://dx.doi.org/10.1089/scd.2018.0119] [PMID: 30234437]
[21]
Manassero M, Paquet J, Deschepper M, et al. Comparison of survival and osteogenic ability of human mesenchymal stem cells in orthotopic and ectopic sites in mice. Tissue Eng Part A 2016; 22(5-6): 534-44.
[http://dx.doi.org/10.1089/ten.tea.2015.0346] [PMID: 26896389]
[22]
Regan MC, Barbul A. The role of the immune system in the regulation of wound repair. Clin Mater 1991; 8: 197-201.
[http://dx.doi.org/10.1016/0267-6605(91)90032-B]
[23]
Gan JHY. Characterisation of bone defect models in immunodeficient animals. NSW, Australia: The University of New South Wales 2005.
[24]
Zwingenberger S, Niederlohmann E, Vater C, et al. Establishment of a femoral critical-size bone defect model in immunodeficient mice. J Surg Res 2013; 181(1): e7-e14.
[http://dx.doi.org/10.1016/j.jss.2012.06.039] [PMID: 22765996]
[25]
Loi F, Córdova LA, Zhang R, et al. The effects of immunomodulation by macrophage subsets on osteogenesis in vitro. Stem Cell Res Ther 2016; 7: 15.
[http://dx.doi.org/10.1186/s13287-016-0276-5] [PMID: 26801095]
[26]
Weiss ARR, Dahlke MH. Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of action of living, apoptotic, and dead MSCs. Front Immunol 2019; 10: 1191.
[http://dx.doi.org/10.3389/fimmu.2019.01191] [PMID: 31214172]
[27]
Gerstenfeld LC, Cho TJ, Kon T, et al. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs 2001; 169(3): 285-94.
[http://dx.doi.org/10.1159/000047893] [PMID: 11455125]
[28]
Lyons FG, Al-Munajjed AA, Kieran SM, et al. The healing of bony defects by cell-free collagen-based scaffolds compared to stem cell-seeded tissue engineered constructs. Biomaterials 2010; 31(35): 9232-43.
[http://dx.doi.org/10.1016/j.biomaterials.2010.08.056] [PMID: 20863559]
[29]
Mohamed-Ahmed S, Fristad I, Lie SA, et al. Adipose-derived and bone marrow mesenchymal stem cells: A donor-matched comparison. Stem Cell Res Ther 2018; 9(1): 168.
[http://dx.doi.org/10.1186/s13287-018-0914-1] [PMID: 29921311]
[30]
Ho-Shui-Ling A, Bolander J, Rustom LE, Johnson AW, Luyten FP, Picart C. Bone regeneration strategies: Engineered scaffolds, bioactive molecules and stem cells current stage and future perspectives. Biomaterials 2018; 180: 143-62.
[http://dx.doi.org/10.1016/j.biomaterials.2018.07.017] [PMID: 30036727]

Rights & Permissions Print Cite
Article Metrics
20
1
© 2024 Bentham Science Publishers | Privacy Policy